This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1975 Jun 5;255(5508):487-8.

doi: 10.1038/255487a0.

Suppression of tumour growth in mice by a drug-antibody conjugate using a novel approach to linkage

G F Rowland, G J O'Neill, D A Davies

PMID: 1138199
DOI: 10.1038/255487a0

Suppression of tumour growth in mice by a drug-antibody conjugate using a novel approach to linkage

G F Rowland et al. Nature. 1975.

. 1975 Jun 5;255(5508):487-8.

doi: 10.1038/255487a0.

Authors

G F Rowland, G J O'Neill, D A Davies

PMID: 1138199
DOI: 10.1038/255487a0

No abstract available

PubMed Disclaimer

Similar articles

Protection of mice against syngeneic lymphomata: II. Collaboration between drugs and antibodies.
Davies DA, Buckham S, Manstone AJ. Davies DA, et al. Br J Cancer. 1974 Oct;30(4):305-11. doi: 10.1038/bjc.1974.197. Br J Cancer. 1974. PMID: 4217194 Free PMC article.
Protection of mice against syngeneic lymphomata: I. Use of antibodies.
Davies DA, Manstone AJ, Buckham S. Davies DA, et al. Br J Cancer. 1974 Oct;30(4):297-304. doi: 10.1038/bjc.1974.196. Br J Cancer. 1974. PMID: 4217193 Free PMC article.
Effect of immunization on the spread of transplanted mouse lymphoma cells.
Klein E. Klein E. J Natl Cancer Inst. 1973 Dec;51(6):1991-2. doi: 10.1093/jnci/51.6.1991. J Natl Cancer Inst. 1973. PMID: 4587755 No abstract available.
Immunotoxin therapy of malignancy.
Grossbard ML, Nadler LM. Grossbard ML, et al. Important Adv Oncol. 1992:111-35. Important Adv Oncol. 1992. PMID: 1582669 Review. No abstract available.
Oncostatic-antibody complexes in chemotherapy.
Dullens HF, De Weger RA. Dullens HF, et al. Cancer Chemother Pharmacol. 1980;4(1):29-32. doi: 10.1007/BF00255454. Cancer Chemother Pharmacol. 1980. PMID: 6988099 Review.

See all similar articles

Cited by

Recent advances in the construction of antibody-drug conjugates.
Chudasama V, Maruani A, Caddick S. Chudasama V, et al. Nat Chem. 2016 Feb;8(2):114-9. doi: 10.1038/nchem.2415. Epub 2016 Jan 4. Nat Chem. 2016. PMID: 26791893
Antibody-drug conjugates: the paradigm shifts in the targeted cancer therapy.
Aggarwal D, Yang J, Salam MA, Sengupta S, Al-Amin MY, Mustafa S, Khan MA, Huang X, Pawar JS. Aggarwal D, et al. Front Immunol. 2023 Aug 21;14:1203073. doi: 10.3389/fimmu.2023.1203073. eCollection 2023. Front Immunol. 2023. PMID: 37671162 Free PMC article. Review.
The clinical development of antibody-drug conjugates - lessons from leukaemia.
Jabbour E, Paul S, Kantarjian H. Jabbour E, et al. Nat Rev Clin Oncol. 2021 Jul;18(7):418-433. doi: 10.1038/s41571-021-00484-2. Epub 2021 Mar 23. Nat Rev Clin Oncol. 2021. PMID: 33758376 Review.
Antibodies as specific carriers for chemotherapeutic agents.
Lee FH, Hwang KM. Lee FH, et al. Cancer Chemother Pharmacol. 1979;3(1):17-24. doi: 10.1007/BF00254415. Cancer Chemother Pharmacol. 1979. PMID: 394875 Review. No abstract available.
Targeting doxorubicin to epidermal growth factor receptors by site-specific conjugation of C225 to poly(L-glutamic acid) through a polyethylene glycol spacer.
Vega J, Ke S, Fan Z, Wallace S, Charsangavej C, Li C. Vega J, et al. Pharm Res. 2003 May;20(5):826-32. doi: 10.1023/a:1023454107190. Pharm Res. 2003. PMID: 12751641

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database